Best Relief For Heartburn In Wesley Chapel, FL

Standard reflux testing measures reflux above the lower esophageal sphincter only. Laryngopharyngeal reflux produces symptoms above the upper esophageal sphincter, in the throat and voice box, which standard testing does not reach. That gap is why so many people with silent reflux are told their reflux test was normal.

Dr. Grandhige uses a customized 24-hour pH impedance dual-channel probe that records at both levels: above the lower sphincter and above the upper sphincter. The impedance component matters as much as the second channel, because the throat reacts to non-acid reflux too. Bile, pepsin and trypsin do not register on acid-only testing.

The sensitivity difference between the two areas is not subtle. The esophagus can tolerate 40 to 50 reflux episodes a day. The larynx and pharynx can produce symptoms from a single episode a day. Small amounts of reflux in the wrong place cause large symptoms, which is exactly why the standard workup keeps coming back clean.

The practical consequence shows up in surgical results. Patients with throat-predominant symptoms are commonly quoted around a 50 percent chance that surgery helps. With dual-channel testing to confirm that reflux is actually reaching the throat and that symptoms correlate with those events, Dr. Grandhige reports symptom improvement in the range of 80 percent. The gain does not come from a better operation. It comes from screening out the people who were never going to benefit. In his practice, roughly 50 to 60 percent of patients presenting with LPR have testing that supports an anti-reflux procedure. The rest are told so directly.

One expectation to set now: throat symptoms respond slowly. Typical heartburn often resolves the night of surgery. LPR symptoms generally take 4 to 6 months to settle. If you are researching silent reflux and LPR before booking, that timeline is worth knowing up front.

There is no best reflux operation. There is the operation that matches your anatomy, your esophageal motility and your priorities, and sometimes the right answer is no operation. Dr. Grandhige performs all three current procedures with regularity, which means procedure selection is driven by your testing rather than by what a surgeon is most comfortable doing.

Fundoplication wraps the upper stomach around the lower esophagus to reinforce the failing valve, and repairs the hiatal hernia at the same time. It comes in several configurations, and the choice is made from your manometry results: Nissen is a full 360-degree wrap, Toupet is a posterior 270, Watson is an anterior 270, and Dor is an anterior partial. Weaker esophageal function points toward a partial wrap. The operation runs about 1.5 to 2 hours, is done robotically or laparoscopically, and most patients go home the same day. Diet progresses over 2 to 3 months. It is the most durable option and the best answer for large hernias. The trade-off is honest: depending on the configuration, it can limit your ability to burp or vomit, and gas bloating is more common than with the alternatives. Full details are on the fundoplication page.

LINX is a ring of magnetic titanium beads placed around the lower esophagus. It does not raise resting sphincter pressure. It resists opening when stomach pressure rises and opens normally when you swallow, so most patients keep the ability to burp and vomit once early swelling resolves, and bloating is generally less of an issue. Two corrections worth making here. First, hernia size does not disqualify you from LINX, as long as the hernia is repaired during the same operation. That is a widespread misconception. Second, LINX depends on good esophageal motility, and there is a real honest negative: people who are unusually attuned to internal sensation, the ones who could feel a Bravo capsule sitting in the esophagus, frequently report feeling the device. Current LINX devices are MRI compatible up to 1.5 Tesla.

TIF is performed entirely through the mouth with an endoscope and the EsophyX device, with no incisions, in about 45 to 60 minutes. It rebuilds an internal valve and restores the angle of His. What it cannot do is repair the diaphragm, and that limitation defines who it suits. TIF is for people with no hiatal hernia or a very small one, mild to moderate disease, and no Barrett’s esophagus, severe esophagitis or stricture. Dr. Grandhige does not offer TIF to patients outside those criteria, including patients who are obese. He quotes the failure rate plainly at roughly 2 percent per year, or about 20 percent per decade. His framing: it is the best endoscopic procedure that exists, and it should be understood as something that works well for years rather than as a permanent repair.

Two developments this year are worth knowing about, and neither one appears on most local heartburn pages yet.

RefluxStop received FDA premarket approval on August 20, 2026. Implantica announced the approval after a full FDA review that included five-year clinical data. The device works on a different principle from everything else available. It does not encircle the esophagus or apply pressure to it the way a wrap or a magnetic ring does. Instead it repositions the gastroesophageal junction back below the diaphragm and holds it there, restoring the natural anatomy rather than adding resistance. The European five-year outcomes, including data on dysphagia, gas bloating and ability to belch, are published in peer-reviewed literature.

Tampa Bay Reflux Institute is adding RefluxStop, which will make Dr. Grandhige the only surgeon in the Tampa Bay area offering all four anti-reflux procedures. Being direct about the timing: the U.S. rollout is staged and requires site activation and surgeon training at each center, so this is not something being scheduled today. Ask about it at your consultation and you will get a current answer rather than a marketing one.

On the medication side, vonoprazan (Voquezna) is now available. It is the first potassium-competitive acid blocker approved in the United States, and it is a real pharmacologic advance. P-CABs bind reversibly, are stable in acid, and are not affected by the presence of food, so unlike most PPIs it does not have to be timed around meals.

Here is where Dr. Grandhige’s view diverges from most coverage of it. A better acid blocker is still an acid blocker. If your reflux is driven by a 4 cm hiatal hernia and a sphincter that has stopped closing, a faster and steadier rise in stomach pH does not repair the diaphragm and does not stop the reflux events. It changes what is in the fluid moving upward. For symptom control while you go through testing, it is a reasonable option to discuss with your prescriber. As an answer to the question of why this is happening to you, it is not one.

Dr. Grandhige has practiced foregut surgery in Tampa Bay since 2009, founding Tampa Bay Reflux Center in 2009 and Tampa Bay Reflux Institute in 2022. He completed his undergraduate degree in biology at Johns Hopkins University, earned his medical degree at the University of Michigan, and completed his general surgery residency along with fellowships in Burn and Critical Care and in Foregut and Minimally Invasive Surgery at Yale-New Haven Hospital. He is a Founding Member of the American Foregut Society, a member of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), and a Fellow of the American College of Surgeons. He holds privileges at St. Joseph’s Main Hospital, St. Joseph’s South Hospital, HCA Brandon Hospital and HCA South Tampa Hospital, and performs all surgery at HCA South Tampa. His practice covers benign foregut disease only: GERD, hiatal hernias, laryngopharyngeal reflux, achalasia and gastroparesis.

Board certification can be verified through the American Board of Surgery physician lookup and the American College of Surgeons directory. Active Florida licensure can be verified through the Florida Department of Health Medical Quality Assurance license lookup.